Morgan Stanley Has Lowered Expectations for Integral Ad Science (NASDAQ:IAS) Stock Price

Integral Ad Science (NASDAQ:IAS) had its price target reduced by investment analysts at Morgan Stanley from $13.50 to $12.50 in a research report issued on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 91.72% from the company’s current price.

A number of other equities analysts have also recently weighed in on the company. Scotiabank began coverage on Integral Ad Science in a report on Friday, February 28th. They issued a “sector perform” rating and a $12.00 price target for the company. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a research note on Friday, February 28th. Truist Financial lifted their price target on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a “buy” rating in a research note on Monday, March 3rd. Baird R W cut shares of Integral Ad Science from a “strong-buy” rating to a “hold” rating in a research report on Friday, March 28th. Finally, Oppenheimer reiterated an “outperform” rating on shares of Integral Ad Science in a research report on Friday, February 28th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $14.35.

Integral Ad Science Stock Up 1.7 %

NASDAQ:IAS opened at $6.52 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The company’s fifty day moving average price is $8.85 and its 200-day moving average price is $10.10. Integral Ad Science has a 1-year low of $6.32 and a 1-year high of $13.62. The firm has a market capitalization of $1.07 billion, a P/E ratio of 32.60, a PEG ratio of 1.06 and a beta of 1.53.

Integral Ad Science (NASDAQ:IAS) last posted its earnings results on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million during the quarter, compared to analyst estimates of $148.83 million. During the same quarter in the prior year, the firm earned $0.06 earnings per share. The business’s revenue for the quarter was up 13.9% on a year-over-year basis. As a group, equities research analysts anticipate that Integral Ad Science will post 0.26 EPS for the current year.

Insider Buying and Selling

In other news, CEO Lisa Utzschneider sold 8,547 shares of the company’s stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $6.85, for a total value of $58,546.95. Following the transaction, the chief executive officer now directly owns 341,271 shares in the company, valued at approximately $2,337,706.35. This represents a 2.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders have sold 90,303 shares of company stock worth $706,660. 2.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Integral Ad Science

A number of hedge funds have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Integral Ad Science by 4.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company’s stock valued at $433,000 after buying an additional 1,832 shares during the last quarter. Jennison Associates LLC increased its stake in Integral Ad Science by 3.3% in the 4th quarter. Jennison Associates LLC now owns 63,538 shares of the company’s stock valued at $663,000 after purchasing an additional 2,046 shares in the last quarter. Oppenheimer & Co. Inc. raised its position in Integral Ad Science by 8.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company’s stock worth $293,000 after acquiring an additional 2,069 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Integral Ad Science by 7.4% in the fourth quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company’s stock valued at $332,000 after acquiring an additional 2,188 shares in the last quarter. Finally, Arizona State Retirement System boosted its position in Integral Ad Science by 12.5% during the fourth quarter. Arizona State Retirement System now owns 23,404 shares of the company’s stock worth $244,000 after acquiring an additional 2,601 shares during the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.